Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

Saved in:
Bibliographic Details
Published in:Blood cancer journal (New York) 2018-08, Vol.8 (9), p.80-7, Article 80
Main Authors: Gore, Lia, Locatelli, Franco, Zugmaier, Gerhard, Handgretinger, Rupert, O'Brien, Maureen M, Bader, Peter, Bhojwani, Deepa, Schlegel, Paul-Gerhardt, Tuglus, Catherine A, von Stackelberg, Arend
Format: Article
Language:English
Subjects:
Adolescent
Antibodies, Bispecific - administration & dosage
Antibodies, Bispecific - adverse effects
Antibodies, Bispecific - therapeutic use
Antineoplastic Agents, Immunological - administration & dosage
Antineoplastic Agents, Immunological - adverse effects
Antineoplastic Agents, Immunological - therapeutic use
Child
Child, Preschool
Combined Modality Therapy
Correspondence
Follow-Up Studies
Hematopoietic Stem Cell Transplantation
Humans
Immunotherapy, Adoptive
Infant
Kaplan-Meier Estimate
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality
Transplantation, Homologous
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2044-5385
2044-5385
DOI:10.1038/s41408-018-0117-0